Literature DB >> 12138127

Essential role of p38 mitogen-activated protein kinase in contact hypersensitivity.

Yoko Takanami-Ohnishi1, Shinya Amano, Sadao Kimura, Sachie Asada, Atsushi Utani, Masumi Maruyama, Hiroyuki Osada, Hajime Tsunoda, Yoko Irukayama-Tomobe, Katsutoshi Goto, Michael Karin, Tatsuhiko Sudo, Yoshitoshi Kasuya.   

Abstract

The present study was designed to elucidate the role of p38 mitogen-activated protein kinase (p38) in the pathogenesis of inflammation, using a mouse contact hypersensitivity (CHS) model induced by 2,4-dinitro-1-fluorobenzene (DNFB). Ear swelling was induced by challenge with DNFB, accompanied by infiltration of mononuclear cells, neutrophils, and eosinophils and a marked increase in mRNA levels of cytokines such as interleukin (IL)-2, interferon (IFN)-gamma, IL-4, IL-5, IL-1beta, IL-18, and tumor necrosis factor-alpha in the challenged ear skin. Both ear swelling and the number of infiltrated cells in DNFB-challenged ear skin were significantly inhibited by treatment with SB202190, a p38 inhibitor. Furthermore, the DNFB-induced expression of all cytokines except IL-4 was significantly inhibited by treatment with SB202190. Ribonuclease protection assay revealed that the mRNA levels of chemokines such as IP-10 and MCP-1 in ear skin were markedly increased at 24 h after challenge with DNFB. The induction of these chemokines was significantly inhibited by treatment with SB202190. In p38alpha +/- mice, both ear swelling and infiltration of cells induced by DNFB were reduced compared with those in wild-type mice. However, induction of cytokines by DNFB was also observed in p38alpha +/- mice, although the induction of IFN-gamma, IL-5, and IL-18 was typically reduced compared with that in wild-type mice. Challenge with DNFB slightly induced IP-10 and MCP-1 mRNA in p38alpha +/- mice, with weaker signals than those in SB202190-treated wild-type mice. These results suggest that p38 plays a key role in CHS and is an important target for the treatment of CHS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12138127     DOI: 10.1074/jbc.M207326200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Mechanism for p38α-mediated experimental autoimmune encephalomyelitis.

Authors:  Kana Namiki; Hirofumi Matsunaga; Kento Yoshioka; Kensuke Tanaka; Kazuya Murata; Junji Ishida; Akira Sakairi; Jundal Kim; Naoki Tokuhara; Nobuhiko Shibakawa; Motohisa Shimizu; Yukinori Wada; Yasunori Tokunaga; Manabu Shigetomi; Masahiko Hagihara; Sadao Kimura; Tatsuhiko Sudo; Akiyoshi Fukamizu; Yoshitoshi Kasuya
Journal:  J Biol Chem       Date:  2012-05-25       Impact factor: 5.157

2.  Differential modulation of keratin expression by sulforaphane occurs via Nrf2-dependent and -independent pathways in skin epithelia.

Authors:  Michelle Kerns; Daryle DePianto; Masayuki Yamamoto; Pierre A Coulombe
Journal:  Mol Biol Cell       Date:  2010-10-06       Impact factor: 4.138

3.  An eosinophil immune response characterizes the inflammatory skin disease observed in Tie-2 transgenic mice.

Authors:  Daniel Voskas; Yael Babichev; Ling S Ling; Jennifer Alami; Yuval Shaked; Robert S Kerbel; Brian Ciruna; Daniel J Dumont
Journal:  J Leukoc Biol       Date:  2008-05-01       Impact factor: 4.962

4.  In vitro and in vivo immunosuppressive activity of a novel anthracycline, 13-deoxy, 5-iminodoxorubicin.

Authors:  Richard D Olson; Mark B Headley; Alma Hodzic; Gerald M Walsh; Denise G Wingett
Journal:  Int Immunopharmacol       Date:  2007-02-14       Impact factor: 4.932

5.  Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation.

Authors:  Francesca Mascia; Valentina Mariani; Giampiero Girolomoni; Saveria Pastore
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

6.  Auf1/Hnrnpd-deficient mice develop pruritic inflammatory skin disease.

Authors:  Navid Sadri; Robert J Schneider
Journal:  J Invest Dermatol       Date:  2008-10-02       Impact factor: 8.551

Review 7.  In vivo functions of mitogen-activated protein kinases: conclusions from knock-in and knock-out mice.

Authors:  Nancy Gerits; Sergiy Kostenko; Ugo Moens
Journal:  Transgenic Res       Date:  2007-01-12       Impact factor: 3.145

8.  MAPK usage in periodontal disease progression.

Authors:  Qiyan Li; Michael S Valerio; Keith L Kirkwood
Journal:  J Signal Transduct       Date:  2012-01-23

9.  Topical alpha-selective p38 MAP kinase inhibition reduces acute skin inflammation in guinea pig.

Authors:  Satyanarayana Medicherla; Jing Ying Ma; Mamtha Reddy; Irina Esikova; Irene Kerr; Fabiola Movius; Linda S Higgins; Andrew A Protter
Journal:  J Inflamm Res       Date:  2010-02-18

10.  Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity.

Authors:  Stefan F Martin; Jan C Dudda; Eva Bachtanian; Annalisa Lembo; Stefanie Liller; Christoph Dürr; Markus M Heimesaat; Stefan Bereswill; György Fejer; Ralitsa Vassileva; Thilo Jakob; Nikolaus Freudenberg; Christian C Termeer; Caroline Johner; Chris Galanos; Marina A Freudenberg
Journal:  J Exp Med       Date:  2008-08-25       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.